This concept is supported by previous studies on hepatocellular and head and neck cancers, which reported lower mutation rates of known cancer-related genes, such as FAT1, CTTNB1, TERT, TP53, in virus-infected individuals (57–59). This evidence concerns the gene TP53 and cancer.